The Germany blastic plasmacytoid dendritic cell neoplasm (BPDCN) market size was valued at USD 142.92 million in 2024, growing at a CAGR of 7.4% from 2025 to 2034, reflecting a confluence of improved diagnostic capabilities, regulatory support for orphan drug development, and expanding access to targeted therapies within the European healthcare ecosystem. As one of the most aggressive...
Greek 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)